MMSI icon

Merit Medical Systems

82.91 USD
+0.04
0.05%
At close Jul 30, 4:00 PM EDT
After hours
82.96
+0.05
0.06%
1 day
0.05%
5 days
-2.68%
1 month
-11.31%
3 months
-12.22%
6 months
-24.83%
Year to date
-13.70%
1 year
-2.46%
5 years
78.15%
10 years
229.40%
 

About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Employees: 7,400

0
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

4,311% more call options, than puts

Call options by funds: $92.8M | Put options by funds: $2.1M

12% more capital invested

Capital invested by funds: $5.9B [Q4 2024] → $6.59B (+$689M) [Q1 2025]

1.3% more ownership

Funds ownership: 104.69% [Q4 2024] → 106.0% (+1.3%) [Q1 2025]

4% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 134

0% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 3 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 51

2% less funds holding

Funds holding: 381 [Q4 2024] → 372 (-9) [Q1 2025]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$108
30%
upside
Avg. target
$110
32%
upside
High target
$112
35%
upside

4 analyst ratings

positive
100%
neutral
0%
negative
0%
Needham
Mike Matson
30%upside
$108
Buy
Reiterated
18 Jul 2025
Piper Sandler
Jason Bednar
33%upside
$110
Overweight
Maintained
23 May 2025
Canaccord Genuity
Jon Young
35%upside
$112
Buy
Maintained
21 May 2025
Wells Fargo
Larry Biegelsen
30%upside
$108
Overweight
Maintained
21 May 2025

Financial journalist opinion

Based on 5 articles about MMSI published over the past 30 days

Positive
Zacks Investment Research
1 week ago
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
Positive
Zacks Investment Research
1 week ago
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Neutral
GlobeNewsWire
3 weeks ago
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit's new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO of Merit through October 3, 2025.
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
Neutral
GlobeNewsWire
3 weeks ago
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Neutral
Zacks Investment Research
4 weeks ago
XRAY or MMSI: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
XRAY or MMSI: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 month ago
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Neutral
Barrons
1 month ago
The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.
Stocks that aren't sensitive to economic ups and downs are a smart way to protect your portfolio.
The Market Is Vulnerable. 6 ‘Defensive' Stocks to Buy Now.
Positive
Zacks Investment Research
2 months ago
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
2 months ago
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Neutral
GlobeNewsWire
2 months ago
Merit Medical Acquires Biolife Delaware, L.L.C.
SOUTH JORDAN, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that it has acquired Biolife Delaware, L.L.C. (“Biolife”) in a merger transaction through which Biolife has become a wholly-owned subsidiary of Merit. Biolife, which is headquartered in Sarasota, Florida, manufactures unique patented hemostatic devices under the brand names StatSeal and WoundSeal.
Merit Medical Acquires Biolife Delaware, L.L.C.
Charts implemented using Lightweight Charts™